SCHEMBL28126126

SCHEMBL28126126

C[C@H](N)c1cc2ccccc2cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2A6 P11509 1/20 0.50
▸ PDPK1 O15530 1/20 0.50
▸ PLAU P00749 1/20 0.42
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ HTR2A P28223 1/20 0.39
▸ HTR2C P28335 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ HTR3A P46098 1/20 0.39
▸ ATM Q13315 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ SLC6A2 P23975 1/20 0.37
▸ SLC6A4 P31645 1/20 0.37
▸ SLC6A3 Q01959 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ IRAK4 Q9NWZ3 1/20 0.36
▸ PDCD1 Q15116 2/20 0.35
▸ CD274 Q9NZQ7 2/20 0.35
▸ S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4372827 1.00 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL2609291 0.83 CYP1A2 (0.54) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL23535876 0.82 CYP1A2 (0.44) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL6638235 0.80 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL30134233 0.80 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL6638354 0.80 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL27508297 0.80 CYP1A2 (0.50) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL31748280 0.79 CYP1A2 (0.46) CYP1A2CYP2A6PDPK1PLAUNPC1
SCHEMBL3635950 0.79 CYP2A6 (0.45) CYP1A2CYP2A6HTR2AHTR2CIRAK4
SCHEMBL3633957 0.79 CYP1A2 (0.46) CYP1A2CYP2A6NPC1RAB9AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104703979-B Heterocyclic compounds and their use 无限药品股份有限公司 2018-11-27 — — CN disclosed
CN-105793255-B Heterocyclic compounds and their use 无限药品股份有限公司 2018-11-16 — — CN disclosed
CN-106456628-A Heterocyclic compounds for the treatment of PI 3K-gamma mediated disorders 无限药品股份有限公司 2017-02-22 — — CN disclosed
Send feedback